Logo image of GRNA

GreenLight Biosciences Holdings PBC (GRNA) Stock Analyst Earnings Estimates

NASDAQ:GRNA - Nasdaq - US39536G1058 - Common Stock - Currency: USD

0.2995  0 (-0.03%)

After market: 0.2995 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2020 2021 2022 2023 2024
Revenue
YoY % growth
GRNA revenue by date.GRNA revenue by date.
1.747M
-41.79%		1.595M
-8.70%		6.78M
325.08%		7.242M
6.81%		17.969M
148.12%
EBITDA
YoY % growth
GRNA ebitda by date.GRNA ebitda by date.
N/A-102.786M-154.884M
-50.69%		-127.194M
17.88%		-126.174M
0.80%
EBIT
YoY % growth
GRNA ebit by date.GRNA ebit by date.
-52.284M
-79.04%		-108.558M
-107.63%		-162.96M
-50.11%		-136.374M
16.31%		-137.394M
-0.75%
Operating Margin
GRNA operating margin by date.GRNA operating margin by date.
-2,992.79%-6,806.14%-2,403.54%-1,883.10%-764.62%
EPS
YoY % growth
GRNA eps by date.GRNA eps by date.
N/AN/AN/A-0.85
26.28%		-0.83
1.74%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q2 / 23 Q3 / 23 Q4 / 23
EPS
Q2Q % growth		-0.27-0.26
10.32%		-0.24
4.12%
Revenue
Q2Q % growth		510K
-71.15%		510K
-70.55%		2.244M
-25.77%
EBITDA
Q2Q % growth		-38.006M
20.56%		-37.781M
-24.44%		-38.108M
-27.42%
EBIT
Q2Q % growth		-30.906M
40.52%		-30.294M
16.40%		-29.478M
22.39%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2022
Q2Q % growth		 -0.25 -0.260.012.16%
GRNA Yearly EPS VS EstimatesGRNA Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 -0.2 -0.4 -0.6 -0.8 -1
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2023
Q2Q % growth		 3.82M
1,386.38%		1.02M2.8M274.51%
Q4 2022
Q2Q % growth		 3.023M
628.43%		1.632M1.391M85.23%
Q3 2022
Q2Q % growth		 1.732M
378.45%		%
Q2 2022
Q2Q % growth		 1.768M
258.62%		%
GRNA Yearly Revenue VS EstimatesGRNA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 5M 10M 15M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-58.24% -7.82% -14.11% -14.11%
Revenue0% 0% 69.05% 69.05%